Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-046793

Director acquired 71 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Behbahani Ali Director 2020-08-13 Other acquisition +57 256 D
Behbahani Ali Director 2020-08-13 Other acquisition +14 14 I
Loading xslF345X03/doc4.xml…